Cargando…
Acid-suppressive Medications and Risk of Esophageal Adenocarcinoma in Patients With Barrett’s Esophagus: (Gut 2014;63:1229–1237)
Autor principal: | Kim, Gwang Ha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Neurogastroenterology and Motility
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398232/ https://www.ncbi.nlm.nih.gov/pubmed/25843080 http://dx.doi.org/10.5056/jnm15004 |
Ejemplares similares
-
Alteration of Fecal Microbiota in Patients With Postinfectious Irritable Bowel Syndrome: (Gut 2014;63:1737–1745)
por: Joo, Young-Eun
Publicado: (2015) -
Does Bile Reflux Influence the Progression of Barrett's Esophagus to Adenocarcinoma? (Gastroenterology 2013;145:1300-1311)
por: Masaoka, Tatsuhiro, et al.
Publicado: (2014) -
Different Quality of Life Between GERD and Barrett's Esophagus (Am J Gastroenterol 2009;104:2695-2703)
por: Nam, Su Youn
Publicado: (2010) -
Columnar-lined Esophagus: Its Prevalence and Predictors in Patients With Gastroesophageal Reflux Disease (Am J Gastroenterol 2012;107:1655-1661)
por: Kim, Gwang Ha
Publicado: (2013) -
New Consensus on the Management of Barrett's Dysplasia and Early Stage Esophageal Adenocarcinoma: Limited Evidence, but Best Available Guidance (Gastroenterology 2012;143:336-346)
por: Jo, Yunju
Publicado: (2012)